These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 37626629)
1. New Diagnostic and Prognostic Models for the Development of Alcoholic Cirrhosis Based on Genetic Predisposition and Alcohol History. Mischitelli M; Spagnoli A; Abbatecola A; Codazzo C; Giacomelli M; Parisse S; Mancina RM; Rotondo C; Attilia F; Ginanni Corradini S; Ferri F Biomedicines; 2023 Jul; 11(8):. PubMed ID: 37626629 [TBL] [Abstract][Full Text] [Related]
2. A two gene-based risk score predicts alcoholic cirrhosis development in males with at-risk alcohol consumption. Mancina RM; Ferri F; Farcomeni A; Molinaro A; Maffongelli A; Mischitelli M; Poli E; Parlati L; Burza MA; De Santis A; Attilia F; Rotondo C; Rando MM; Attilia ML; Ceccanti M; Ginanni Corradini S Appl Clin Genet; 2019; 12():1-10. PubMed ID: 30666147 [TBL] [Abstract][Full Text] [Related]
3. A study of genetic variants, genetic risk score and DNA methylation of PNPLA3 and TM6SF2 in alcohol liver cirrhosis. Shankarappa B; Mahadevan J; Murthy P; Purushottam M; Viswanath B; Jain S; Devarbhavi H; Mysore V A Indian J Gastroenterol; 2023 Dec; 42(6):800-807. PubMed ID: 37589914 [TBL] [Abstract][Full Text] [Related]
4. Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol Misusers. Stickel F; Lutz P; Buch S; Nischalke HD; Silva I; Rausch V; Fischer J; Weiss KH; Gotthardt D; Rosendahl J; Marot A; Elamly M; Krawczyk M; Casper M; Lammert F; Buckley TWM; McQuillin A; Spengler U; Eyer F; Vogel A; Marhenke S; von Felden J; Wege H; Sharma R; Atkinson S; Franke A; Nehring S; Moser V; Schafmayer C; Spahr L; Lackner C; Stauber RE; Canbay A; Link A; Valenti L; Grove JI; Aithal GP; Marquardt JU; Fateen W; Zopf S; Dufour JF; Trebicka J; Datz C; Deltenre P; Mueller S; Berg T; Hampe J; Morgan MY Hepatology; 2020 Jul; 72(1):88-102. PubMed ID: 31630428 [TBL] [Abstract][Full Text] [Related]
5. Combined effects of PNPLA3, TM6SF2 and HSD17B13 variants on severity of biopsy-proven non-alcoholic fatty liver disease. Paternostro R; Staufer K; Traussnigg S; Stättermayer AF; Halilbasic E; Keritam O; Meyer EL; Stift J; Wrba F; Sipos B; Canbay A; Schlattjan M; Aigner E; Datz C; Stickel F; Schafmayer C; Hampe J; Buch S; Prager G; Munda P; Mandorfer M; Ferenci P; Trauner M Hepatol Int; 2021 Aug; 15(4):922-933. PubMed ID: 34076851 [TBL] [Abstract][Full Text] [Related]
6. Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis. Stickel F; Buch S; Nischalke HD; Weiss KH; Gotthardt D; Fischer J; Rosendahl J; Marot A; Elamly M; Casper M; Lammert F; McQuillin A; Zopf S; Spengler U; Marhenke S; Kirstein MM; Vogel A; Eyer F; von Felden J; Wege H; Buch T; Schafmayer C; Braun F; Deltenre P; Berg T; Morgan MY; Hampe J Am J Gastroenterol; 2018 Oct; 113(10):1475-1483. PubMed ID: 29535416 [TBL] [Abstract][Full Text] [Related]
7. Role of candidate gene variants in modulating the risk and severity of alcoholic hepatitis. Beaudoin JJ; Liang T; Tang Q; Banini BA; Shah VH; Sanyal AJ; Chalasani NP; Gawrieh S Alcohol Clin Exp Res; 2021 Apr; 45(4):709-719. PubMed ID: 33616244 [TBL] [Abstract][Full Text] [Related]
8. PNPLA3 I148M (rs738409) genetic variant and age at onset of at-risk alcohol consumption are independent risk factors for alcoholic cirrhosis. Burza MA; Molinaro A; Attilia ML; Rotondo C; Attilia F; Ceccanti M; Ferri F; Maldarelli F; Maffongelli A; De Santis A; Attili AF; Romeo S; Ginanni Corradini S Liver Int; 2014 Apr; 34(4):514-20. PubMed ID: 24102786 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the association of a variant in PNPLA3 and TM6SF2 with fibrosis progression in patients with chronic hepatitis C infection after eradication: A retrospective study. Kang Q; Xu J; Luo H; Tan N; Chen H; Cheng R; Pan J; Han Y; Yang Y; Liu D; Xi H; Yu M; Xu X Gene; 2022 Apr; 820():146235. PubMed ID: 35143946 [TBL] [Abstract][Full Text] [Related]
10. [Effects of PNPLA3, TM6SF2 gene polymorphisms and its interactions with smoking and alcohol drinking on hepatitis B virus-associated hepatocellular carcinoma]. Wang LQ; Guo WH; Guo ZW; Qin P; Zhang R; Zhu XM; Liu DW Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Dec; 39(12):1611-1616. PubMed ID: 30572387 [No Abstract] [Full Text] [Related]
11. [Correlation between PNPLA3 rs738409 and TM6SF2 rs58542926 gene polymorphism and primary liver cancer in the Han Population of China's Northeast region]. Bing H; Wang W; Li YL Zhonghua Gan Zang Bing Za Zhi; 2021 Feb; 29(2):156-162. PubMed ID: 33685085 [No Abstract] [Full Text] [Related]
12. Pediatric non-alcoholic fatty liver disease and kidney function: Effect of Di Sessa A; Umano GR; Cirillo G; Passaro AP; Verde V; Cozzolino D; Guarino S; Marzuillo P; Miraglia Del Giudice E World J Gastroenterol; 2020 Sep; 26(36):5474-5483. PubMed ID: 33024398 [TBL] [Abstract][Full Text] [Related]
13. PNPLA3 rs738409 and TM6SF2 rs58542926 variants increase the risk of hepatocellular carcinoma in alcoholic cirrhosis. Falleti E; Cussigh A; Cmet S; Fabris C; Toniutto P Dig Liver Dis; 2016 Jan; 48(1):69-75. PubMed ID: 26493626 [TBL] [Abstract][Full Text] [Related]
15. Metabolic and Genetic Risk Factors Are the Strongest Predictors of Severity of Alcohol-Related Liver Fibrosis. Israelsen M; Juel HB; Detlefsen S; Madsen BS; Rasmussen DN; Larsen TR; Kjærgaard M; Fernandes Jensen MJ; Stender S; Hansen T; Krag A; Thiele M; Clin Gastroenterol Hepatol; 2022 Aug; 20(8):1784-1794.e9. PubMed ID: 33279778 [TBL] [Abstract][Full Text] [Related]
16. Variants in PCSK7, PNPLA3 and TM6SF2 are risk factors for the development of cirrhosis in hereditary haemochromatosis. Buch S; Sharma A; Ryan E; Datz C; Griffiths WJH; Way M; Buckley TWM; Ryan JD; Stewart S; Wright C; Dongiovanni P; Fracanzani A; Zwerina J; Merle U; Weiss KH; Aigner E; Krones E; Dejaco C; Fischer J; Berg T; Valenti L; Zoller H; McQuillin A; Hampe J; Stickel F; Morgan MY Aliment Pharmacol Ther; 2021 Apr; 53(7):830-843. PubMed ID: 33565643 [TBL] [Abstract][Full Text] [Related]
17. The rs72613567:TA polymorphism in HSD17B13 is associated with survival benefit after development of hepatocellular carcinoma. Innes H; Morgan MY; Hampe J; Stickel F; Buch S Aliment Pharmacol Ther; 2023 Sep; 58(6):623-631. PubMed ID: 37470344 [TBL] [Abstract][Full Text] [Related]
18. Genetic variant rs72613567 of HSD17B13 gene reduces alcohol-related liver disease risk in Chinese Han population. Chen H; Zhang Y; Guo T; Yang F; Mao Y; Li L; Liu C; Gao H; Jin Y; Che Y; Li Y; Huang J Liver Int; 2020 Sep; 40(9):2194-2202. PubMed ID: 33151633 [TBL] [Abstract][Full Text] [Related]
19. High Risk of Fatty Liver Disease Amplifies the Alanine Transaminase-Lowering Effect of a HSD17B13 Variant. Gellert-Kristensen H; Nordestgaard BG; Tybjaerg-Hansen A; Stender S Hepatology; 2020 Jan; 71(1):56-66. PubMed ID: 31155741 [TBL] [Abstract][Full Text] [Related]
20. The rs72613567: TA Variant in the Hydroxysteroid 17-beta Dehydrogenase 13 Gene Reduces Liver Damage in Obese Children. Di Sessa A; Umano GR; Cirillo G; Marzuillo P; Arienzo MR; Pedullà M; Miraglia Del Giudice E J Pediatr Gastroenterol Nutr; 2020 Mar; 70(3):371-374. PubMed ID: 31789772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]